Literature DB >> 31136820

Reslizumab in an invasively ventilated patient with acute respiratory failure.

Andreas Renner1, Katharina Marth2, Lilian Schäffl-Doweik3, Wolfgang Pohl2.   

Abstract

Entities:  

Year:  2019        PMID： 31136820     DOI： 10.1016/j.jaip.2019.05.019

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  2 in total

1.  Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report.

Authors:  Johannes Anthon Kroes; Sander Wilhelm Zielhuis; Carina Bethlehem; Anneke Ten Brinke; Eric Nico Van Roon
Journal:  Eur J Hosp Pharm       Date:  2021-04-21

2.  Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use.

Authors:  Santi Nolasco; Raffaele Campisi; Rossella Intravaia; Morena Porto; Corrado Pelaia; Nunzio Crimi; Claudia Crimi
Journal:  F1000Res       Date:  2020-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.